The identification of key players in HNSCC such as FAT1 and PI3K as regulators of the Hippo-YAP pathway, as well as the activation of YAP as a relevant oncogenic mechanism in head and neck cancer opens the way for the use of different therapeutic strategies targeting this pathway in this tumor type. The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.